Pappagallo, G., and M. Rizzo. “Directness and Quality of Evidence of Bevacizumab Combined With Chemotherapy for Platinum-Resistant, Recurrent Ovarian Cancer in the AURELIA Trial:  ”. Cancer Breaking News, vol. 2, no. 2, Oct. 2014, pp. 39-41, https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/274.